Dementia Debate: How To Diagnose And Treat Alzheimer’s
July 31, 2024
If it feels like there’s an onslaught of information these days about how to diagnose and treat Alzheimer’s dementia, your feelings are valid. New developments and research are coming fast and furious, as academic researchers and for-profit companies race to find effective ways to diagnose Alzheimer’s as early as possible…
Brain Check: Should You Get A Cognitive Test?
July 24, 2024
While we don’t need to mention names, you probably have heard that the concept of “taking a cognitive test” has been in the headlines in recent months. But what exactly is such a test? How do you know whether you should take it? And what will such a test tell…
Evolving Advice: The Latest Insights Regarding Alzheimer’s Treatments
July 10, 2024
In the evolving landscape of the diagnosis and treatment of Alzheimer’s, updates and insights are regularly advancing. We’ve previously reported on the introduction and demise of the first breakthrough “treatment”- Aduhelm- and then on the introduction of Leqembi, the IV-administered antibody intended to slow down the pace of cognitive decline…
Meditation In Motion: Why Tai Chi May Be A Great Choice For You
May 15, 2024
No doubt you know that we’ve frequently touted the importance of physical activity for healthy aging. We’ve also praised the value of mindfulness and meditation to lower stress and anxiety and help put you in a calm, present state of mind (which can also benefit your physical health). If there’s…
Prevention Interventions: Strategies For Addressing Your Alzheimer’s Risk
May 8, 2024
Not so long ago, receiving a diagnosis of Alzheimer’s was a devastating piece of news. Usually, such a diagnosis came after specific symptoms of cognitive decline appeared. Physicians had little to offer beyond recommendations for getting your affairs in order (assuming you still had decision-making capacity when the diagnosis was…
Testing And Treating: The Latest Updates on Alzheimer’s Dementia
January 31, 2024
Last summer, we reported on the FDA approval of Leqembi, a medication that slows down cognitive decline in patients with Mild Cognitive Impairment or early Alzheimer’s Disease. While the medication is now covered by Medicare, patients who want access still have to demonstrate a diagnosis of Alzheimer’s and still have…